MetLife (NYSE:MET) Releases Earnings Results, Beats Expectations By $0.13 EPS

MetLife (NYSE:MET) announced its earnings results on Wednesday. The financial services provider reported $2.43 earnings per share for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13, Zacks reports. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The firm had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the previous year, the firm posted $2.02 EPS. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year.

MetLife Stock Up 3.9%

Shares of MET stock traded up $3.79 during trading hours on Thursday, hitting $100.06. 3,771,848 shares of the company’s stock traded hands, compared to its average volume of 3,817,942. The stock’s fifty day simple moving average is $89.44 and its two-hundred day simple moving average is $80.54. MetLife has a 12-month low of $67.33 and a 12-month high of $100.93. The stock has a market cap of $64.38 billion, a price-to-earnings ratio of 19.39, a PEG ratio of 0.74 and a beta of 0.78. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.53.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.4%. MetLife’s dividend payout ratio (DPR) is currently 45.93%.

Analyst Ratings Changes

Several analysts have commented on the stock. Wall Street Zen lowered shares of MetLife from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Jefferies Financial Group upped their target price on MetLife from $97.00 to $103.00 and gave the stock a “buy” rating in a report on Friday, July 10th. Weiss Ratings upgraded MetLife from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, June 15th. Piper Sandler lifted their price target on MetLife from $86.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Finally, JPMorgan Chase & Co. upped their price target on MetLife from $96.00 to $106.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, MetLife has an average rating of “Moderate Buy” and an average price target of $100.71.

Key Stories Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife reported second-quarter adjusted earnings of $2.43 per share, exceeding the $2.30 analyst consensus and rising from $2.02 a year earlier. Higher investment income, favorable underwriting and business-volume growth supported the earnings beat. MetLife Tops Q2 Earnings Estimates on Strong Investment Income
• Positive Sentiment: Revenue increased 10.5% year over year to approximately $19.1 billion, while management commentary and analyst coverage pointed to resilient organic growth. MetLife’s return on equity was also strong at 22.6%. MetLife Q2 Earnings Beat Reaffirms the Buy Case
• Positive Sentiment: The board authorized a new $3 billion share-repurchase program, incremental to roughly $400 million remaining under the prior authorization. The program could cover up to about 4.8% of outstanding shares, signaling confidence in future capital generation and potentially supporting per-share results. MetLife Announces New $3 Billion Share Repurchase Authorization
• Neutral Sentiment: MetLife maintained its 2026 outlook for MetLife Investment Management operating earnings of $240 million to $280 million. MetLife Pet Insurance also received a 2026 industry award, offering positive brand recognition but limited near-term earnings impact. MetLife Outlines New Buyback Authorization
• Negative Sentiment: Quarterly revenue of approximately $19.1 billion fell short of the $19.67 billion consensus estimate, and higher expenses remain a consideration despite the overall earnings beat. MetLife Quarterly Earnings Results

MetLife declared that its Board of Directors has authorized a share buyback plan on Wednesday, August 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to buy up to 4.8% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Sivia Capital Partners LLC purchased a new position in MetLife in the 2nd quarter worth approximately $404,000. Brighton Jones LLC boosted its stake in MetLife by 9.0% during the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after purchasing an additional 351 shares during the last quarter. DV Equities LLC bought a new stake in shares of MetLife in the 4th quarter worth $61,000. Atlas Capital Advisors Inc. purchased a new position in shares of MetLife in the fourth quarter worth $189,000. Finally, Litman Gregory Wealth Management LLC bought a new position in shares of MetLife during the fourth quarter valued at $83,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.